Periplocin suppresses the growth of colorectal cancer cells by triggering LGALS3 (galectin 3)-mediated lysophagy.

IF 14.6 1区 生物学 Q1 CELL BIOLOGY
Autophagy Pub Date : 2023-12-01 Epub Date: 2023-07-23 DOI:10.1080/15548627.2023.2239042
Kui Wang, Shuyue Fu, Lixia Dong, Dingyue Zhang, Mao Wang, Xingyun Wu, Enhao Shen, Li Luo, Changlong Li, Edouard Collins Nice, Canhua Huang, Bingwen Zou
{"title":"Periplocin suppresses the growth of colorectal cancer cells by triggering LGALS3 (galectin 3)-mediated lysophagy.","authors":"Kui Wang, Shuyue Fu, Lixia Dong, Dingyue Zhang, Mao Wang, Xingyun Wu, Enhao Shen, Li Luo, Changlong Li, Edouard Collins Nice, Canhua Huang, Bingwen Zou","doi":"10.1080/15548627.2023.2239042","DOIUrl":null,"url":null,"abstract":"<p><p>Colorectal cancer (CRC) is one of the most common malignancies worldwide and remains a major clinical challenge. Periplocin, a major bioactive component of the traditional Chinese herb <i>Cortex periplocae</i>, has recently been reported to be a potential anticancer drug. However, the mechanism of action is poorly understood. Here, we show that periplocin exhibits promising anticancer activity against CRC both <i>in vitro</i> and <i>in vivo</i>. Mechanistically, periplocin promotes lysosomal damage and induces apoptosis in CRC cells. Notably, periplocin upregulates LGALS3 (galectin 3) by binding and preventing LGALS3 from Lys210 ubiquitination-mediated proteasomal degradation, leading to the induction of excessive lysophagy and resultant exacerbation of lysosomal damage. Inhibition of LGALS3-mediated lysophagy attenuates periplocin-induced lysosomal damage and growth inhibition in CRC cells, suggesting a critical role of lysophagy in the anticancer effects of periplocin. Taken together, our results reveal a novel link between periplocin and the lysophagy machinery, and indicate periplocin as a potential therapeutic option for the treatment of CRC.<b>Abbreviations:</b> 3-MA: 3-methyladenine; ACACA/ACC1: acetyl-CoA carboxylase alpha; AMPK: adenosine monophosphate-activated protein kinase; AO: Acridine orange; ATG5: autophagy related 5; ATG7: autophagy related 7; CALM: calmodulin; CHX: cycloheximide; CRC: colorectal cancer; CQ: chloroquine; CTSB: cathepsin B; CTSD: cathepsin D; ESCRT: endosomal sorting complex required for transport; LAMP1: lysosomal associated membrane protein 1; LMP: lysosomal membrane permeabilization; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MCOLN1/TRPML1: mucolipin TRP cation channel 1; MKI67/Ki-67: marker of proliferation Ki-67; MTOR: mechanistic target of rapamycin kinase; P2RX4/P2X4: purinergic receptor P2X 4; PARP1/PARP: poly(ADP-ribose) polymerase 1; PRKAA/AMPKα: protein kinase AMP-activated catalytic subunit alpha; SQSTM1/p62: sequestosome 1; TFEB: transcription factor EB; TRIM16: tripartite motif containing 16.</p>","PeriodicalId":8722,"journal":{"name":"Autophagy","volume":" ","pages":"3132-3150"},"PeriodicalIF":14.6000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621285/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Autophagy","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/15548627.2023.2239042","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/23 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Colorectal cancer (CRC) is one of the most common malignancies worldwide and remains a major clinical challenge. Periplocin, a major bioactive component of the traditional Chinese herb Cortex periplocae, has recently been reported to be a potential anticancer drug. However, the mechanism of action is poorly understood. Here, we show that periplocin exhibits promising anticancer activity against CRC both in vitro and in vivo. Mechanistically, periplocin promotes lysosomal damage and induces apoptosis in CRC cells. Notably, periplocin upregulates LGALS3 (galectin 3) by binding and preventing LGALS3 from Lys210 ubiquitination-mediated proteasomal degradation, leading to the induction of excessive lysophagy and resultant exacerbation of lysosomal damage. Inhibition of LGALS3-mediated lysophagy attenuates periplocin-induced lysosomal damage and growth inhibition in CRC cells, suggesting a critical role of lysophagy in the anticancer effects of periplocin. Taken together, our results reveal a novel link between periplocin and the lysophagy machinery, and indicate periplocin as a potential therapeutic option for the treatment of CRC.Abbreviations: 3-MA: 3-methyladenine; ACACA/ACC1: acetyl-CoA carboxylase alpha; AMPK: adenosine monophosphate-activated protein kinase; AO: Acridine orange; ATG5: autophagy related 5; ATG7: autophagy related 7; CALM: calmodulin; CHX: cycloheximide; CRC: colorectal cancer; CQ: chloroquine; CTSB: cathepsin B; CTSD: cathepsin D; ESCRT: endosomal sorting complex required for transport; LAMP1: lysosomal associated membrane protein 1; LMP: lysosomal membrane permeabilization; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MCOLN1/TRPML1: mucolipin TRP cation channel 1; MKI67/Ki-67: marker of proliferation Ki-67; MTOR: mechanistic target of rapamycin kinase; P2RX4/P2X4: purinergic receptor P2X 4; PARP1/PARP: poly(ADP-ribose) polymerase 1; PRKAA/AMPKα: protein kinase AMP-activated catalytic subunit alpha; SQSTM1/p62: sequestosome 1; TFEB: transcription factor EB; TRIM16: tripartite motif containing 16.

Periplocin通过触发LGALS3(半乳糖凝集素3)介导的食道抑制结直肠癌癌症细胞的生长。
癌症(CRC)是全球最常见的恶性肿瘤之一,仍然是一个主要的临床挑战。杠皮苷是中草药杠皮的主要生物活性成分,近年来被报道为一种潜在的抗癌药物。然而,人们对其作用机制知之甚少。在这里,我们证明了紫苏霉素在体外和体内对CRC都表现出有希望的抗癌活性。从机制上讲,紫苏霉素促进溶酶体损伤并诱导CRC细胞凋亡。值得注意的是,外plocin通过结合并阻止LGALS3的Lys210泛素化介导的蛋白酶体降解来上调LGALS3(半乳糖凝集素3),导致过度的裂解诱导和溶酶体损伤的恶化。对LGALS3介导的裂解抑制减弱了紫苏霉素诱导的CRC细胞溶酶体损伤和生长抑制,表明裂解在紫苏霉肽的抗癌作用中起着关键作用。总之,我们的研究结果揭示了紫苏霉素与溶食管机制之间的新联系,并表明紫苏霉肽是治疗CRC的潜在治疗选择。缩写:3-MA:3-甲基腺嘌呤;ACACA/ACC1:乙酰辅酶A羧化酶α;AMPK:腺苷酸活化蛋白激酶;AO:吖啶橙;ATG5:自噬相关5;ATG7:自噬相关7;CALM:钙调蛋白;CHX:环己酰亚胺;结直肠癌:癌症;CQ:氯喹;CTSB:组织蛋白酶B;CTSD:组织蛋白酶D;ESCRT:运输所需的内体分选复合体;LAMP1:溶酶体相关膜蛋白1;LMP:溶酶体膜透化;MAP1LC3B/LC3B:微管相关蛋白1轻链3β;MCOLN1/TRPML1:粘脂蛋白TRP阳离子通道1;MKI67/Ki-67:增殖标志物Ki-67;MTOR:雷帕霉素激酶的机制靶点;P2RX4/P2X4:嘌呤能受体P2X4;PARP1/PARP:聚ADP核糖聚合酶1;PRKAA/AMPKα:蛋白激酶AMP活化的催化亚基α;SQSTM1/p62:螯合体1;TFEB:转录因子EB;TRIM16:包含16。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Autophagy
Autophagy 生物-细胞生物学
CiteScore
21.30
自引率
2.30%
发文量
277
审稿时长
1 months
期刊介绍: Autophagy is a peer-reviewed journal that publishes research on autophagic processes, including the lysosome/vacuole dependent degradation of intracellular material. It aims to be the premier journal in the field and covers various connections between autophagy and human health and disease, such as cancer, neurodegeneration, aging, diabetes, myopathies, and heart disease. Autophagy is interested in all experimental systems, from yeast to human. Suggestions for specialized topics are welcome. The journal accepts the following types of articles: Original research, Reviews, Technical papers, Brief Reports, Addenda, Letters to the Editor, Commentaries and Views, and Articles on science and art. Autophagy is abstracted/indexed in Adis International Ltd (Reactions Weekly), EBSCOhost (Biological Abstracts), Elsevier BV (EMBASE and Scopus), PubMed, Biological Abstracts, Science Citation Index Expanded, Web of Science, and MEDLINE.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信